Nasopharyngeal carcinoma Clinical Trials
Conditions / Nasopharyngeal carcinoma
Delta Trials records 411 clinical trials for Nasopharyngeal carcinoma in its publicly accessible dataset. From the full dataset, 86 actively seeking eligible participants and 93 trials have reached completion. This research is conducted across 798 study locations around the world. An additional 232 trials are active but not currently open for enrollment. Since 2020, 20 trials have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
411
Total Trials
86
Recruiting
93
Completed
232
Other Active
20
Terminated since 2020
798
Study Locations
Browse by location (798 total)
- Guangzhou, China 176 trialsAll trials in Guangzhou, China
- Shanghai, China 43 trialsAll trials in Shanghai, China
- Hangzhou, China 30 trialsAll trials in Hangzhou, China
- Nanning, China 29 trialsAll trials in Nanning, China
- Fuzhou, China 26 trialsAll trials in Fuzhou, China
- Nanchang, China 21 trialsAll trials in Nanchang, China
- Beijing, China 19 trialsAll trials in Beijing, China
- Changsha, China 19 trialsAll trials in Changsha, China
- Wuhan, China 18 trialsAll trials in Wuhan, China
- Singapore, Singapore 17 trialsAll trials in Singapore, Singapore
- Houston, United States 14 trialsAll trials in Houston, United States
- Zhongshan, China 14 trialsAll trials in Zhongshan, China
- Chengdu, China 14 trialsAll trials in Chengdu, China
- Taipei, Taiwan 14 trialsAll trials in Taipei, Taiwan
- Taipei, Taiwan 14 trialsAll trials in Taipei, Taiwan
- Hong Kong, Hong Kong 13 trialsAll trials in Hong Kong, Hong Kong
- Wuzhou, China 13 trialsAll trials in Wuzhou, China
- Boston, United States 11 trialsAll trials in Boston, United States
- Zhuhai, China 11 trialsAll trials in Zhuhai, China
- Chongqing, China 11 trialsAll trials in Chongqing, China